Helsinki - Delayed Quote EUR

Orion Oyj (ORNBV.HE)

Compare
45.13
+0.19
+(0.42%)
At close: January 10 at 6:29:50 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,429,100.00
1,189,600.00
1,340,700.00
1,041,000.00
1,078,100.00
Cost of Revenue
573,200.00
531,900.00
489,000.00
447,500.00
434,400.00
Gross Profit
855,900.00
657,700.00
851,700.00
593,500.00
643,700.00
Operating Expense
448,900.00
392,500.00
415,400.00
355,800.00
367,300.00
Operating Income
407,000.00
265,200.00
436,300.00
237,700.00
276,400.00
Net Non Operating Interest Income Expense
-2,600.00
-2,800.00
-800.00
-1,200.00
-1,000.00
Pretax Income
413,900.00
271,900.00
440,300.00
242,300.00
278,300.00
Tax Provision
82,300.00
--
--
--
--
Net Income Common Stockholders
331,700.00
216,800.00
349,500.00
193,800.00
219,900.00
Diluted NI Available to Com Stockholders
331,700.00
216,800.00
349,500.00
193,800.00
219,900.00
Basic EPS
2.36
1.54
2.49
1.38
1.56
Diluted EPS
2.36
1.54
2.49
1.38
1.56
Basic Average Shares
140,438.90
140,326.68
140,501.28
140,546.56
140,506.97
Diluted Average Shares
140,532.80
140,361.04
140,589.74
140,563.90
140,506.97
Total Operating Income as Reported
416,700.00
274,900.00
439,600.00
243,300.00
280,100.00
Total Expenses
1,022,100.00
924,400.00
904,400.00
803,300.00
801,700.00
Net Income from Continuing & Discontinued Operation
331,700.00
216,800.00
349,500.00
193,800.00
219,900.00
Normalized Income
325,370.84
210,503.70
349,182.40
190,600.00
219,662.95
Interest Income
--
2,900.00
1,000.00
100.00
200.00
Interest Expense
--
5,200.00
1,500.00
1,000.00
900.00
Net Interest Income
-2,600.00
-2,800.00
-800.00
-1,200.00
-1,000.00
EBIT
418,900.00
277,100.00
441,800.00
243,300.00
279,200.00
EBITDA
418,900.00
328,600.00
489,300.00
289,100.00
335,700.00
Reconciled Cost of Revenue
573,200.00
531,900.00
489,000.00
447,500.00
434,400.00
Reconciled Depreciation
--
51,500.00
47,500.00
45,800.00
56,500.00
Net Income from Continuing Operation Net Minority Interest
331,700.00
216,800.00
349,500.00
193,800.00
219,900.00
Total Unusual Items Excluding Goodwill
7,900.00
7,900.00
400.00
4,000.00
300.00
Total Unusual Items
7,900.00
7,900.00
400.00
4,000.00
300.00
Normalized EBITDA
411,000.00
320,700.00
488,900.00
285,100.00
335,400.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,570.84
1,603.70
82.40
800.00
62.95
12/31/2020 - 10/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VIRP.PA Virbac SA
318.00
-1.40%
 
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
53.35
-1.20%
 
RO.SW Roche Holding AG
287.00
-1.37%
 
SAN.PA Sanofi
95.61
-0.72%
 
GRF.MC Grifols, S.A.
9.06
-0.57%
 
NOVN.SW Novartis AG
91.09
-0.60%
 
AZN.L AstraZeneca PLC
10,982.00
-0.05%
 
GSK.L GSK plc
1,349.50
0.00%
 
BAYN.DE Bayer Aktiengesellschaft
19.98
+1.13%
 
NOVO-B.CO Novo Nordisk A/S
632.30
+0.37%